First Turn Management’s Vaxcyte PCVX Stock Holding History

First Turn Management's PCVX Position: Q2 2026 in Review

First Turn Management opened a new position in Vaxcyte (PCVX) in Q2 2026: 443,836 shares worth $25.8M. The stake represents 2.76% of the portfolio and ranks #17 among its holdings. This is a return to the name: First Turn Management previously reported a position in PCVX as recently as Q1 2025.

First Turn Management first reported a position in PCVX in Q4 2023 and has held it in 7 quarters since. 332 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

• First Turn Management held 443,836 shares of Vaxcyte worth $25.8M as of Q2 2026.
• Vaxcyte was a new First Turn Management position in Q2 2026.
• Vaxcyte made up 2.76% of First Turn Management's portfolio in Q2 2026, its #17 holding.
• First Turn Management first reported a position in Vaxcyte in Q4 2023 and has held it in 7 quarters since.
• 332 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on First Turn Management's 13F filing for Q2 2026, filed 14 Aug 2026.